1229607-67-3

Upstream product

• 1736-87-4 2,3-dimethyl-4-fluoro-1-nitro-benzene 
• 33631-05-9 2-amino-4-hydroxypyridine 

Downstream Products

• 1229607-68-4 N-(4-(2,3-dimethyl-4-nitrophenoxy)pyridin-2-yl)-2-methoxyacetamide 
• 1338815-44-3 1-(4-(2,3-dimethyl-4-nitrophenoxy)pyridin-2-yl)-3-methylurea 
• 1338815-45-4 1-(4-(4-amino-2,3-dimethylphenoxy)pyridin-2-yl)-3-methylurea 

Relevant academic research and scientific papers

P38 MAP KINASE INHIBITORS

There is provided a compound of formula (I): wherein: J represents (A): or (B): compositions comprising same, processes for preparing said compounds and use thereof in treatment, particularly in the treatment of inflammatory disease, such as asthma, COPD and 15 rheumatoid arthritis.

P38 MAP KINASE INHIBITORS

The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes,particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD